$JBIO 3 SEC Filings

Filed On	Filing
26 Jun 2026	Form 3: Eisner Mark, Director No securities owned
14 Jul 2025	Form 3: Dahms Bradford D., Chief Financial Officer No securities owned
01 May 2025	Form 3: Fairmount Funds Management Llc, Director and 3 others Holds 564,551 shares of Common Stock
01 May 2025	Form 3: Lavelle Erin, Director
01 May 2025	Form 3: Klein Lawrence Otto, Director Holds 86,215 shares of Common Stock
01 May 2025	Form 3: Cain Christopher W., Director No securities owned
01 May 2025	Form 3: Dobmeier Eric, Director
01 May 2025	Form 3: Balta Elizabeth, See Remarks
01 May 2025	Form 3: Kocinsky Hetal, Chief Medical Officer
01 May 2025	Form 3: King Andrew James, See Remarks Holds 344,863 shares of Common Stock
01 May 2025	Form 3: Quick Jonathan, See Remarks
01 May 2025	Form 3: Frohlich Tom, Director
11 Jul 2023	Form 3: Dable Habib J, Director No securities owned
08 Mar 2023	Form 3: Pigot Timothy, Chief Commercial Officer Holds 1,960 shares of Common Stock
23 Jan 2023	Form 3: Santel Donald J, Director No securities owned
23 Mar 2022	Form 3: Verwijs Marinus, Senior Vice President, CMC No securities owned
19 Jul 2021	Form 3: Dorval Allison, Director No securities owned
29 Jun 2021	Form 3: Atlas Venture Fund XII, L.p., 10% owner and 2 others
29 Jun 2021	Form 3: Grayzel David S., Director
29 Jun 2021	Form 3: Ra Capital MANAGEMENT, L.p., Director and 4 others Holds 241,467 shares of Common Stock

Comments